Clinical Trials Logo

Immunocompromised clinical trials

View clinical trials related to Immunocompromised.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT05545319 Withdrawn - Hospitalization Clinical Trials

A Study to Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People With Weakened Immune Systems or at Increased Risk for Poor Outcomes Who Are Hospitalized Due to Severe COVID-19

EPIC-HOS
Start date: December 13, 2022
Phase: Phase 2
Study type: Interventional

A Study to Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People with Weakened Immune Systems or at Increased Risk for Poor Outcomes who are Hospitalized Due to Severe COVID-19